Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
J Endocrinol Invest ; 45(12): 2299-2311, 2022 Dec.
Article in English | MEDLINE | ID: mdl-35867330

ABSTRACT

PURPOSE: Enobosarm (EN), a selective androgen receptor modulator and raloxifene (RAL), a selective estrogen receptor modulator, have been shown to improve bone tissue in osteoporotic males. The present study evaluated the effects of a combination therapy of EN and RAL on bone properties in orchiectomized rats compared to the respective single treatments. METHODS: Eight-month-old male Sprague-Dawley rats were either left intact (Non-Orx) or orchiectomized (Orx). The Orx rats were divided into four groups (n = 15 each): 1) Orx, 2) EN treatment (Orx + EN), 3) RAL treatment (Orx + RAL), 4) combined treatment (Orx + EN + RAL). EN and RAL (0.4 mg and 7 mg/kg body weight/day) were applied immediately after Orx with a soy-free pelleted diet for up to 18 weeks. The lumbar spine and femora were examined by micro-CT, biomechanical, histomorphological, ashing, and gene expression analyses. RESULTS: EN exhibited an anabolic effect on bone, improving some of its parameters in Orx rats, but did not affect biomechanical properties. RAL exhibited antiresorptive activity, maintaining the biomechanical and trabecular parameters of Orx rats at the levels of Non-Orx rats. EN + RAL exerted a stronger effect than the single treatments, improving most of the bone parameters. Liver weight increased after all treatments; the kidney, prostate, and levator ani muscle weights increased after EN and EN + RAL treatments. BW was reduced due to a decreased food intake in the Orx + RAL group and due a reduced visceral fat weight in the Orx + EN + RAL group. CONCLUSION: The EN + RAL treatment appeared to be promising in preventing male osteoporosis, but given the observed side effects on liver, kidney, and prostate weights, it requires further investigation.


Subject(s)
Androgens , Bone Density , Rats , Male , Animals , Androgens/pharmacology , Rats, Sprague-Dawley , Estrogen Receptor Modulators/pharmacology , Orchiectomy , Raloxifene Hydrochloride/pharmacology , Lumbar Vertebrae , Selective Estrogen Receptor Modulators/pharmacology
2.
Am J Transplant ; 16(11): 3150-3162, 2016 11.
Article in English | MEDLINE | ID: mdl-27273729

ABSTRACT

Experimentally, regulatory T cells inhibit rejection. In clinical transplantations, however, it is not known whether T cell regulation is the cause for, or an epiphenomenon of, long-term allograft survival. Here, we study naïve and alloantigen-primed T cell responses of clinical lung transplant recipients in humanized mice. The pericardiophrenic artery procured from human lung grafts was implanted into the aorta of NODrag-/- /IL-2rγc-/- mice reconstituted with peripheral blood mononuclear cells (PBMCs) from the respective lung recipient. Naïve or primed allogeneic PBMCs procured 21 days post-lung transplantation with or without enriching for CD4+ CD25high T cells were used. Transplant arteriosclerosis was assessed 28 days later by histology. Mice reconstituted with alloantigen-primed PBMCs showed significantly more severe transplant arteriosclerosis than did mice with naïve PBMCs (p = 0.005). Transplant arteriosclerosis was equally suppressed by enriching for autologous naïve (p = 0.012) or alloantigen-primed regulatory T cells (Tregs) (p = 0.009). Alloantigen priming in clinical lung recipients can be adoptively transferred into a humanized mouse model. Transplant arteriosclerosis elicited by naïve or alloantigen-primed PBMCs can be similarly controlled by potent autologous Tregs. Cellular therapy with expanded autologous Tregs in lung transplantation might be a promising future strategy.


Subject(s)
Arteriosclerosis/etiology , Graft Rejection/etiology , Graft Survival/immunology , Isoantigens/immunology , Lung Diseases/immunology , Lung Transplantation/adverse effects , T-Lymphocytes, Regulatory/immunology , Animals , Female , Humans , Leukocytes, Mononuclear/immunology , Lung Diseases/surgery , Male , Mice , Mice, Inbred NOD , Middle Aged , Phenotype , Transplant Recipients , Transplantation, Homologous
3.
Dtsch Med Wochenschr ; 117(9): 332-6, 1992 Feb 28.
Article in German | MEDLINE | ID: mdl-1544353

ABSTRACT

One week after relapsing a 44-year-old female alcoholic and drug addict developed a psycho-organic syndrome. Later she had swallowing and speech dysfunctions and became quadriplegic, the result of central pontine myelinolysis. The signs became most marked in the 5th week of illness and then gradually improved, but an independent existence became impossible. There were no electrolyte disorders. Computed tomography demonstrated the typical lesion (a hypodense focus in the pons, 1 cm in diameter) after the 3rd week, findings confirmed by magnetic resonance imaging. The acoustic evoked potentials were unremarkable. An abnormal eye-closure reflex suggested medulla oblongata damage. The diagnosis of central pontine myelinolysis is difficult because the typical brainstem lesions become demonstrable by various imaging techniques only after some delay.


Subject(s)
Demyelinating Diseases , Pons , Alcoholism/complications , Demyelinating Diseases/diagnosis , Demyelinating Diseases/diagnostic imaging , Female , Humans , Magnetic Resonance Imaging , Middle Aged , Neurocognitive Disorders/etiology , Pons/diagnostic imaging , Substance-Related Disorders/complications , Time Factors , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...